Melita Sun Jung's Insider Trades & SAST Disclosures

Melita Sun Jung's most recent trade in Terns Pharmaceuticals Inc was a trade of 325,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Terns Pharmaceuticals Inc
Melita Sun Jung Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 325,000 325,000 - - Stock Option (Right to Buy)
Terns Pharmaceuticals Inc
Melita Sun Jung Chief Business Officer Purchase of securities on an exchange or from another person at price $ 5.11 per share. 30 Jan 2025 2,250 2,250 - 5.1 11,498 Common Stock
Terns Pharmaceuticals Inc
Melita Sun Jung Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 475,000 475,000 - - Stock Option (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades